Amphastar Pharmaceuticals Inc (AMPH)
44.54
+0.45
(+1.02%)
USD |
NASDAQ |
Nov 21, 16:00
44.54
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals Price to Book Value: 2.943 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.913 |
| November 19, 2024 | 2.882 |
| November 18, 2024 | 2.918 |
| November 15, 2024 | 2.948 |
| November 14, 2024 | 2.977 |
| November 13, 2024 | 3.005 |
| November 12, 2024 | 3.152 |
| November 11, 2024 | 3.209 |
| November 08, 2024 | 3.192 |
| November 07, 2024 | 3.045 |
| November 06, 2024 | 3.528 |
| November 05, 2024 | 3.407 |
| November 04, 2024 | 3.343 |
| November 01, 2024 | 3.352 |
| October 31, 2024 | 3.359 |
| October 30, 2024 | 3.376 |
| October 29, 2024 | 3.400 |
| October 28, 2024 | 3.418 |
| October 25, 2024 | 3.343 |
| October 24, 2024 | 3.299 |
| October 23, 2024 | 3.312 |
| October 22, 2024 | 3.349 |
| October 21, 2024 | 3.378 |
| October 18, 2024 | 3.380 |
| October 17, 2024 | 3.304 |
| Date | Value |
|---|---|
| October 16, 2024 | 3.379 |
| October 15, 2024 | 3.278 |
| October 14, 2024 | 3.277 |
| October 11, 2024 | 3.162 |
| October 10, 2024 | 3.077 |
| October 09, 2024 | 3.079 |
| October 08, 2024 | 3.076 |
| October 07, 2024 | 3.113 |
| October 04, 2024 | 3.106 |
| October 03, 2024 | 3.079 |
| October 02, 2024 | 3.091 |
| October 01, 2024 | 3.214 |
| September 30, 2024 | 3.226 |
| September 27, 2024 | 3.296 |
| September 26, 2024 | 3.286 |
| September 25, 2024 | 3.207 |
| September 24, 2024 | 3.253 |
| September 23, 2024 | 3.336 |
| September 20, 2024 | 3.376 |
| September 19, 2024 | 3.438 |
| September 18, 2024 | 3.417 |
| September 17, 2024 | 3.338 |
| September 16, 2024 | 3.321 |
| September 13, 2024 | 3.301 |
| September 12, 2024 | 3.193 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.535
Minimum
Mar 20 2020
5.389
Maximum
Aug 08 2023
2.946
Average
2.774
Median
Price to Book Value Benchmarks
| Eli Lilly and Co | 49.99 |
| BridgeBio Pharma Inc | -- |
| NovaBay Pharmaceuticals Inc | 3.291 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.263 |
Price to Book Value Related Metrics
| PE Ratio | 14.85 |
| PS Ratio | 3.231 |
| PEG Ratio | 0.8638 |
| Price to Free Cash Flow | 13.74 |
| Price | 44.54 |
| Earnings Yield | 6.74% |
| Market Cap | 2.142B |
| PEGY Ratio | 0.8638 |
| Operating PE Ratio | 10.91 |
| Normalized PE Ratio | 14.85 |